Perceived Prescription Opioid and Medical Cannabis‐Related Stigma Among US Adults With and Physicians Who Treat Chronic Pain
Drug and Alcohol Review · 2026
DOI: 10.1111/dar.70212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Review, 2026. Verfasst von Sarah Gutkind und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Medical Marijuana, Chronic Pain, Analgesics, Opioid, Social Stigma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Introduction
Stigma may influence prescription opioid and cannabis use for pain management among people experiencing and physicians treating chronic pain. We assessed differences in perceived stigma around prescription opioids and cannabis for chronic pain among these two groups.
Methods
Data were from surveys of adults with chronic pain and physicians in 36 states and DC with medical cannabis laws, administered in March–April 2022 and July–August 2023, respectively. Stigma was measured as whether respondents believed they would be treated unfairly by neighbours, family or employers if using prescription opioids/cannabis for chronic pain. We compared survey‐weighted estimates of perceived prescription opioid and cannabis stigma between patients and physicians using chi‐squared tests and developed stigma scales (range: 1 [low stigma]–5 [high stigma]) to compare average stigma scores for each substance within subgroups.
Results
Compared to adults with chronic pain, physicians were more likely to believe they would be treated unfairly for managing chronic pain with prescription opioids by neighbours (39.3% vs. 18.4%, p value < 0.001), family (32.8% vs. 17.4%, p value < 0.001) and employers (49.8% vs. 29.8%, p value < 0.001). Findings were consistent for cannabis. Prescription opioid stigma scores were lower than cannabis scores among adults with chronic pain (2.73 vs. 2.83) and physicians (3.22 vs. 3.33). Discussion and Conclusions Relative to adults with chronic pain, physicians were more likely to perceive stigma around prescription opioid or cannabis use. Both perceived more stigma associated with cannabis than prescription opioids for pain management. Group differences may reflect clinical guidance around opioid and cannabis for chronic pain, and substance differences may reflect cannabis's federal illegality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Population Health Sciences, Weill Cornell Medicine, New York, New York, USA.
- Department of Psychiatry, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
ORCID-Profile: Emma E McGinty, Elizabeth M Stone, Kayla N Tormohlen
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Gutkind, S., McGinty, E. E., Stone, E. M., & Tormohlen, K. N. (2026). Perceived Prescription Opioid and Medical Cannabis‐Related Stigma Among US Adults With and Physicians Who Treat Chronic Pain. Drug and Alcohol Review. https://doi.org/10.1111/dar.70212
Vancouver
Gutkind S, McGinty EE, Stone EM, Tormohlen KN. Perceived Prescription Opioid and Medical Cannabis‐Related Stigma Among US Adults With and Physicians Who Treat Chronic Pain. Drug and Alcohol Review. 2026. doi:10.1111/dar.70212
BibTeX
@article{Gutkind2026,
author = {Gutkind, Sarah and McGinty, Emma E and Stone, Elizabeth M and Tormohlen, Kayla N},
title = {Perceived Prescription Opioid and Medical Cannabis‐Related Stigma Among US Adults With and Physicians Who Treat Chronic Pain},
journal = {Drug and Alcohol Review},
year = {2026},
doi = {10.1111/dar.70212}
}
EUVIMED